CA-4948 in Combination With FOLFOX/PD-1 Inhibitor +/- Trastuzumab for Untreated Unresectable Gastric and Esophageal Cancer
Washington University School of Medicine
Washington University School of Medicine
Ono Pharmaceutical Co. Ltd
Arcus Biosciences, Inc.
Bristol-Myers Squibb
Neonc Technologies, Inc.
Centre Leon Berard
I-Mab Biopharma US Limited
AstraZeneca
Aulos Bioscience, Inc.
Pfizer
ImmunityBio, Inc.
Mayo Clinic